Although Uganda participated in a groundbreaking trial for Lenacapavir—an injectable drug proven effective in preventing ...

Rwanda is among the countries interested in Lenacapavir, a newly approved, long-acting preventive injection, though its cost is seemingly out of reach for many developing countries.

Chicago-area groups that support LGBTQ+ individuals are navigating an uncertain landscape while bracing for federal funding ...

Why a twice‑yearly injection might prove to be a good shot Lenacapavir is a first-in-class HIV drug that works by targeting ...

The $400 million the United States congress removed from a list of funding programmes the Trump administration wants to cut doesn’t cancel the cuts to HIV and TB programmes made in February ...

President Donald Trump is removing a large portion of HIV funding he previously greenlit for a future without AIDs. For ...

This month, the White House released a statement that confirmed Trump “underwent a comprehensive examination” that revealed he had chronic venous insufficiency. Here's what that means, according to ...